Skip to main content

A Phase 3, Randomized, Double-Blind, Adaptive, Placebo/Paclitaxel-Controlled Study of AVB-S6-500 in Combination with Paclitaxel in Patients with Platinum-Resistant Recurrent Ovarian Cancer

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

GOG Foundation

Start Date

September 1, 2021

End Date

September 14, 2026
 

Administered By

Duke Cancer Institute

Awarded By

GOG Foundation

Start Date

September 1, 2021

End Date

September 14, 2026